Advertisement

Cerebral and Visceral Organ Gangliosides and Related Glycolipids in GM1-Gangliosidosis Type 1, Type 2 and Chronic Type

  • Tamotsu Taketomi
  • Atsushi Hara
  • Tooru Kasama
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 174)

Abstract

GMl-gangliosidosis is an autosomal recessive hereditary disease caused by deficiency of lysosomal acid β-galactosidase. Recent studies 1,2 have indicated that most of GMl-gangliosidoses can be clinically classified into three types: infantile Type 1, juvenile Type 2 and adult Chronic Type. Also, a genetic and biochemical study3 has suggested that the phenotypic variation found in GMl-gangliosidosis results from different alleic mutations affecting the GM1 β -galactosidase locus, and that different combinations of these mutations account for the clinical heterogeneity of this disease. However, it seems that further biochemical investigation still remains to be carried out on storage substances in cerebral and visceral organs of patients with GMl-gangliosidosis. We have recently studied gangliosides and related glycolipids in brain, liver, spleen and kidney of Type 1, Type 2 and Chronic Type patients. These experimental results which showed chemically characteristic properties in each Type will be presented and discussed here.

Keywords

Visceral Organ Chronic Type Neutral Glycolipid Simple Lipid Alleic Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J. S. O’Brien, Molecular genetics of GM1-galactosidase, Clin, Genet, 8:303 (1975).CrossRefGoogle Scholar
  2. 2.
    T. Kobayashi and K. Suzuki, Chronic GM1 gangliosidosis presenting as dystonia: II Biochemical Studies, Ann. Neurol. 9:476 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    D. F. Farrell and U. Ochs, GM1 gangliosidosis: Phenotypic variation in a single family, Ann. Neurol. 9:225 (1981).PubMedCrossRefGoogle Scholar
  4. 4.
    K. Suzuki, The pattern of mammalian brain gangliosides II. Evaluation of the extraction procedure, post-mortem changes and the effect of formalin preservation, J. Neurochem. 12:629 (1965).PubMedCrossRefGoogle Scholar
  5. 5.
    G. R. Bartlett, Phosphorus assay in column chromatography, J. Biol. Chem. 234:466 (1959).PubMedGoogle Scholar
  6. 6.
    R. W. Ledeen, R. K. Yu, and L. F. Eng, Gangliosides of human myelin: Sialosylgalactosylceramide (G7) as a major component, J. Neurochem. 21:829 (1973).PubMedCrossRefGoogle Scholar
  7. 7.
    T. Taketomi and N. Kawamura, Chemical and immunological characterization of caprine erythrocyte glycolipids in comparison with porcine erythrocyte glycolipids. J. Biochem. 72:799 (1972).PubMedGoogle Scholar
  8. 8.
    L. R. Phillips and B. A. Frasser, Methylation of carbohydrates with dimsyl potassium in dimethyl sulfoxide, Carbohydrate Res. 90:149 (1981).CrossRefGoogle Scholar
  9. 9.
    K. Stellner, H. Saito, and S. Hakomori, Determination of amino-sugar linkages in glycolipids by methylation, Arch. Biochem. Biophys. 155:464 (1973).PubMedCrossRefGoogle Scholar
  10. 10.
    K. Suzuki, Y. Suzuki, and S. Kamoshita, Chemical pathology of GMl-gangliosidosis (generalized gangliosidosis), J. Neuropath. Exp. Neurol. 28:25 (1969).PubMedCrossRefGoogle Scholar
  11. 11.
    L. S. Wolfe, R. G. Senior, and N. M. K. Ng Ying Kim, The structure of oligosaccharides accumulating in the liver of GMl-gangliosidosis Type 1, J. Biol. Chem. 249:1828 (1974).PubMedGoogle Scholar
  12. 12.
    K. Yamashita, T. Ohkura, S. Okada, H. Yabuuchi, and A. Kobata, Urinary oligosaccharides of GMl-gangliosidosis, J. Biol. Chem. 256:4789 (1981).PubMedGoogle Scholar
  13. 13.
    D. F. Farrell and M. P. MacMartin, GM1 gangliosidosis: Enzymatic variation in a single family, Ann. Neurol. 9:232 (1981).PubMedCrossRefGoogle Scholar
  14. 14.
    K. Suzuki and Y. Suzuki, Globoid cell leucodystrophy (Krabbe’s Disease): Deficiency of galactocerebroside-galactosi-dase, Proc. Natl. Acad. Sci. USA 66:302 (1970).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Tamotsu Taketomi
    • 1
  • Atsushi Hara
    • 1
  • Tooru Kasama
    • 1
  1. 1.Department of Biochemistry, Institute of Adaptation MedicineShinshu University School of MedicineMatsumoto 390Japan

Personalised recommendations